首页> 美国卫生研究院文献>Cell Death Disease >SIRT1 suppresses the migration and invasion of gastric cancer by regulating ARHGAP5 expression
【2h】

SIRT1 suppresses the migration and invasion of gastric cancer by regulating ARHGAP5 expression

机译:SIRT1通过调节ARHGAP5表达抑制胃癌的迁移和侵袭

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Gastric cancer (GC) ranks among the top five malignant tumors worldwide by the incidence and mortality rate. However, the mechanisms underlying its progression are poorly understood. In this study, we investigated the role of SIRT1, a class III deacetylase, in the invasion and metastasis of GC. Here, we found that knockdown of SIRT1 promoted GC cell migration and invasion in vitro and metastasis in vivo. Forced expression of SIRT1 in GC cells had the opposite effects. Then, we used mRNA microarray to identify the target genes that are regulated by SIRT1 and found that ARHGAP5 was downregulated by SIRT1. The results of the mRNA microarray were confirmed in several GC cell lines. Furthermore, SIRT1 inhibited the expression of ARHGAP5 by physically associating with transcription factor c-JUN and deacetylating and inhibiting the transcriptional activity of c-JUN. Then the expression dynamics and clinical significance of ARHGAP5 were analyzed using clinical samples and database. The expression of ARHGAP5 was increased in GC, and positively correlated with tumor size, tumor infiltration, lymph node metastasis, and clinical stage. And multivariate analyses indicated that ARHGAP5 served as an independent prognostic marker of GC. In addition, the biological effects of ARHGAP5 in SIRT1-mediated inhibition of GC migration and invasion were investigated using both in vitro and in vivo models. Silencing of ARHGAP5 considerably inhibited the migration and invasion of GC, and ARHGAP5 was found to be involved in the SIRT1-mediated inhibition of GC migration and invasion. Our results indicate that SIRT1 suppresses migration and invasion of GC by downregulating ARHGAP5 through an interaction with c-JUN, and these phenomena represent a novel mechanism of the antitumor action of SIRT1.
机译:从发病率和死亡率来看,胃癌(GC)跻身全球前五名恶性肿瘤之列。但是,对其进展的机制了解得很少。在这项研究中,我们调查了SIRT1(III类脱乙酰基酶)在GC侵袭和转移中的作用。在这里,我们发现敲低SIRT1促进了GC细胞在体外的迁移和侵袭以及体内的转移。 SIRT1在GC细胞中的强制表达具有相反的作用。然后,我们使用mRNA芯片鉴定了SIRT1调控的靶基因,发现ARHGAP5被SIRT1下调。 mRNA芯片的结果在几种GC细胞系中得到证实。此外,SIRT1通过与转录因子c-JUN物理结合并脱乙酰化并抑制c-JUN的转录活性来抑制ARHGAP5的表达。然后使用临床样本和数据库分析ARHGAP5的表达动态和临床意义。 GC中ARHGAP5的表达增加,与肿瘤的大小,浸润,淋巴结转移和临床分期呈正相关。多因素分析表明,ARHGAP5是GC的独立预后指标。此外,还使用体内和体外模型研究了ARHGAP5在SIRT1介导的GC迁移和侵袭抑制中的生物学作用。沉默ARHGAP5会大大抑制GC的迁移和入侵,并且发现ARHGAP5参与SIRT1介导的GC迁移和入侵的抑制。我们的结果表明,SIRT1通过与c-JUN相互作用下调ARHGAP5来抑制GC的迁移和侵袭,这些现象代表了SIRT1的抗肿瘤作用的新机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号